Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Bioorg Med Chem Lett. 2010 Aug 21;20(21):6306–6309. doi: 10.1016/j.bmcl.2010.08.076

Table 2.

In vitro activity of the (Z)-methyl 2-(2-oxo-2H-benzo[b][1,4]oxazin-3(4H)ylidene)acetatesa

graphic file with name nihms238271t1.jpg

Compound R1 R2 R3 IC50b
(µM)
Ki
(µM)
Ki
(µM)
MICc (µg/ml)
1 H H H 10.0±1.0 9.1±1.2 67.0±7.9 0.64
2 Me H H 24.1±1.8 25
3 H Me H 23.1±1.0 >100
4 H F H 27.0±3.0 11.5±1.5 10.1±0.9 0.63
5 H Cl H 46.3±3.5 22.5±1.1 18.5±2.6 5
6 H NO2 H 28.2±4.4 50
7 H EtSO2 H 17.9±3.0 >100
8 H H Me 18.2±2.8 100
9 H H F 30.0±3.7 0.63
10 H H Cl 35.7±4.8 0.63
11 H H NO2 20.3±1.8 >100
12 graphic file with name nihms238271t2.jpg >122 >100
13 graphic file with name nihms238271t3.jpg >140 >100
a

MenB concentration was 150 nM.

b

Compound concentration giving 50% inhibition of enzyme activity.

c

Compound concentration giving 90% inhibition of M. tuberculosis H37Rv growth.